2026-04-17T15:50:34Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/2240562025-11-19T22:35:52Zcom_2072_1057col_2072_478798col_2072_478917

Documento de consenso para la solicitud de pruebas de coagulación preoperatorias Jover Pinillos, Jose Luis Ferrandis Comes, Raquel Llau Pitarch, Juan Vicente Zamudio Penko, Diana R. Basora Macaya, Misericordia Colomina Soler, M. J. (María José) Abad Gurumeta, Alfredo García Fernández, Javier Anestesiologia Coagulació sanguínia Cura preoperatòria Anesthesiology Blood coagulation Preoperative care Introduction: Standard pre-operative coagulation tests are insensitive to certain haemostatic abnormalities, yet they continue to be ordered routinely. Given the lack of clear guidance in Spain, we used Delphi methodology to develop a series of consensus recommendations on ordering these tests. Material and methods: We conducted a 3-round, online, multicentre Delphi study in which 10 expert anaesthesiologists were asked to recruit colleagues to form a panel of 59 anaesthesiologists, 50 of which completed all rounds. The panel rated 46 statements on a 1-9 Likert scale. Consensus was achieved when ≥70% of questions scored ≥7 in the third round. Accepted statements were classified as Weak (70%-79%), Moderate (80%-89%) or Strong (90%-100%) agreement. Results: Twenty-nine statements were accepted. These were synthesized into 21 statements that were grouped into 6 categories: general indication, patient risk factors, procedure characteristics, global assessment, paediatric patients, and special cases. Agreement was strong for 14 statements, moderate for 5, and weak for 2. Key recommendations were: (1) avoid universal testing; (2) base testing on medical history, standard bleeding-risk questionnaires, and specific risk factors (anticoagulation, liver disease, kidney failure, haematopoietic disorders); (3) order tests before high-complexity or high-bleeding-risk procedures; and (4) use specific tests in patients receiving direct oral anticoagulants. Conclusions: Pre-operative coagulation testing is indicated in patients that present bleeding disorders and/or are scheduled for a high-bleeding-risk procedure. 2025-11-03T18:44:51Z 2025-09-11 2025-11-03T18:44:51Z info:eu-repo/date/embargoEnd/2026-09-10 info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion 0034-9356 https://hdl.handle.net/2445/224056 761460 http://hdl.handle.net/2445/224056 eng Versió postprint del document publicat a: https://doi.org/10.1016/j.redare.2025.501931 Revista Española de Anestesiología y Reanimación, 2025, vol. 72, num.9 https://doi.org/10.1016/j.redare.2025.501931 cc-by-nc-nd (c) Sociedad Española de Anestesiología, 2025 http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/embargoedAccess 11 p. application/pdf application/pdf Elsevier España Articles publicats en revistes (Ciències Clíniques)